Tumour necrosis factor alpha is elevated in serum and cerebrospinal fluid in multiple sclerosis and inflammatory neuropathies

Journal of Neurology

Volumn 243, Issue 2, 1996, Pages 165-170

  Rentzos, M ^a   Nikolaou, C ^a   Rombos, A ^a   Voumvourakis, K ^a   Segditsa, I ^a   Papageorgiou, C ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Inflammatory neuropathies; Multiple sclerosis; Tumour necrosis factor alpha

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ARTICLE; CEREBROSPINAL FLUID; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; NEUROPATHY; PATHOGENESIS; PRIORITY JOURNAL; SERUM;

ADOLESCENT; ADULT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; INFLAMMATION; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NERVOUS SYSTEM DISEASES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030029701     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02444010     Document Type: Article

References (61)

1. Arai K, Lee F, Miyajima A, et al. (1990) Cytokines: coordinators of immune and inflammatory responses. Annu Rev Biochem 59:783-836
2. Bansil S, Minthen FA, Cook SD, Sheffer A, Rohowsky Kochan C (1991) Clinical correlation with serum-soluble interleukin-2 receptor levels in GBS. Neurology 41:1302-1305
3. Beck J, Rondot P, Catinot L, Falcoff F, Kirchner H, Wietzerbin J (1988) Increased production of interferon-γ and TNF precedes clinical manifestation in MS: do cytokines trigger off exacerbations? Acta Neurol Scand 78:318-323
4. Brosnan CF, Selmaj K, Raine CS (1988) Hypothesis: a role for tumor necrosis factor in immune-mediated demyelination and its relevance to multiple sclerosis. J Neuroimmunol 18: 87-94
5. Chensue SW, Remick DG, Shmyr-Forsch C, Beals TF, Kunkel SL (1988) Immunohistochemical demonstration of cytoplasmic and membrane-associated tumor necrosis factor in murine macrophages. Am J Pathol 133:564-572
6. Dinarello CA, Mier JW (1987) Lymphokines. N Engl J Med 325:467-472
7. Dinarello CA, Cannon JG, Wolff SM et al. (1986) TNF (cachectin) is an endogenous pyrogen and induces produc-tion of IL-1. J Exp Med 163:1433-1450
8. Dyck PJ, Lais AC, Ohta M, Bastron JA, Okazaki H, Groover RV (1975) Chronic inflammatory polyradiculopathy. Mayo Clin Proc 50:621-637
9. Dyck PJ, Arnason BGW (1984) Chronic inflammatory demyelinating polyradiculoneuropathy. In: Dyck PJ, Thomas PK, Lambert EH, Bunge R (eds) Peripheral neuropathy. Saunders Philadelphia, pp 2101-2115
10. Economou JS, McBride WH, Essner R, et al. (1989) Tumour necrosis factor production by IL2-activated macrophages in vitro and in vivo. Immunology 67:514-519
11. Exley AR, Smith N, Winer JB (1994) Tumour necrosis factor-α and other cytokines in Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 57: 1118-1120
12. Ferraiolo BL, Moore JA, Crase D, Gribling P, Wilking H, Baughman RA (1988) Pharmacokinetics and tissue distribution of recombinant human TNFα in mice. Drug Metab Dispos 16: 270-275
13. Franciotta D, Grimaldi L, Martino GV, Piccolo G, Bergamaschi R, Citterio A, Melzi d'Evil GV (1989) TNF in serum and CSF of patients with MS. Ann Neurol 26:787-789
14. Gallo P, Piccinno MG, Kyralic L, Tavolato B (1989) TNFα and neurological diseases. Failure in detecting TNFα in the CSF from patients with MS, AIDS dementia complex and brain tumours. J Neuroimmunol 23: 41-44
15. Golaz J, Steek A, Moretta L (1983) Activated T-lymphocytes in patients with multiple sclerosis. Neurology 33: 1371-1373
16. Hafler DA, Fox DA, Manning ME, Schlossum SF, Reinherzand FL, Weiner HL (1985) In vivo activated T lymphocytes in the peripheral blood and CSF of patients with MS. N Engl J Med 312:1
17. Hartung HP, Toyka KV (1990) T cell and macrophage activation in experimental autoimmune neuritis (EAN) and the GBS. Ann Neurol 27 [Suppl]: 57-63
18. Hartung HP, Heininger K, Schafer B, et al (1988) Immune mechanisms in inflammatory polyneuropathy. Ann NY Acad Sci 540:122-161
19. Hartung HP, Hughes RAC, Taylor WA, Heininger K, Reiners K, Toyka KV (1990) T cell activation in Guillain-Barré syndrome and in MS: elevated serum levels of soluble IL2 receptors. Neurology 40:215-218
20. Hartung HP, Schafer B, Meide PH van der, Fierz W, Heininger K, Toyka KV (1990) The role of interferon-gamma in the pathogenesis of experimental autoimmune disease of the peripheral nervous system. Ann Neurol 27:247-257
21. Hartung HP, Schmidt B, Toyka KV (1991) Immune activation in Guillain-Barré syndrome: cytokine studies (abstract). Ann Neurol 30:304
22. Hartung HP, Reiners K, Schmidt B, Stoll G, Toyka KV (1991) Serum interleukin-2 concentrations in Guillain-Barré syndrome and CIDP: comparison with other neurological diseases of presumed immunopathogenesis. Ann Neurol 30:48-53
23. Hartung HP, Jung S, Stoll G, Zielasek J, Schmidt B, Archelos JJ, Toyka KV (1992) Inflammatory mediators in demyelinating disorders of the CNS and PNS. J Neuroimmunol 40:197-210
24. Hartung HP, Stoll G, Toyka KV (1993) Immune reactions in the peripheral nervous system. In: Dyck P, et al (eds) Peripheral neuropathy, 3rd edn. Saunders, Philadelphia, pp 418-444
25. Hauser SL, Blan AK, Gilles F, Kemp M, Kerr C, Wriner HL (1986) Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesions. Ann Neurol 19:578-587
26. Hauser SL, Doolittle TH, Lincoln R, Brown RH, Dinarello CA (1990) Cytokine accumulations in CSF of MS patients. Frequent detection of IL-1 and TNF but not IL-6. Neurology 40: 1735-1739
27. Hofman FM, Hinton DR, Johnson K, Merill JE (1989) Tumor necrosis factor identified in multiple sclerosis. J Exp Med 170:607-612
28. Hughes RAC (1992) Immunological mechanisms of demyelination. J R Soc Med 85:53-57
29. Ilyas AA, Wilson HJ, Quarles RH et al (1988) Serum antibodies to gangliosides in GBS. Ann Neurol 23:440-447
30. Jiang H, Stewart CA, Fast DJ, Leu RW (1992) Tumor target-derived soluble factor synergizes with INF-γ and IL2 to activate macrophages for tumor necrosis factor and nitric oxide production to mediate cytotoxicity of the same target. J Immunol 149:2137-2146
31. Koski CL, Chou DKH, Jungalwala FB (1989) Anti-peripheral nerve myelin antibodies in GBS bind a neutral glycolipid of peripheral myelin and cross-react with Forssman antigen. J Clin Invest 84:280-287
32. Laterre EC, Calletweart A, Heremans JF, Sfaello Z (1970) Electrophoretic morphology of gamma globulin in CSF in multiple sclerosis and other diseases of the nervous system. Neurology 20: 982-990
33. Lieberman AP, Pith PM, Shin HS, Shin ML (1989) Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus. Proc Natl Acad Sci USA
34. Link H, Tibbling G (1977) Principle of albumin and IgG in neurological disorders. 2. Relation of the concentration of the proteins in serum and the CSF. Scand J Clin Lab Invest 37:391-395
35. Maimone D, Gregory S, Arnason BGW, Reder AT (1991) Cytokine levels in the CSF and serum of patients with MS. J Neuroimmunol 32:67-74
36. Maimone D, Annunziata P, Simone IL, Livrea P, Guazzi GC (1993) Interleukin-6 levels in the CSF and serum of patients with GBS and CIDP. J Neuroimmunol 47:55-62
37. Matthews N, Neale ML (1987) Studies on the mode of action of tumor necrosis factor on tumor cells in vivo. Lymphokines 14:223-252
38. McLaughlin PJ, Elmwood NJ. Ramadi LT, Pica MR, McKenzie IF (1990) Improvement in sensitivity of enzyme-linked immunosorbent assay of TNF. Immunol Cell Biol 68:51-55
39. Merrill JE, Strom SR, Ellison GW, Myers LW (1989) in vitro study of mediators in MS. J Clin Immunol 9:84-96
40. Minz M, Rapaport R, Oleske JM, Connor EM, Koenigsberger MR, Denny T, Epstein LG (1989) Elevated serum levels of tumor necrosis factor are associated with progressive encephalopathy in children with acquired immunodeficiency syndrome. Am J Dis Child 143: 771-774
41. Mizel SB (1989) The interleukines. FASEBJ 3:2379-2388
42. Mustafa MM, Lebel MH, Ramilo O, Olsen KD, Reisch JS, Bentler B, McCracken G (1989) Correlation of interleukin-1 beta and cachectin concentrations in cerebrospinal fluid and outcome from bacterial meningitis. J Pediatr 115:208-213
43. Nedwin GE, Svedersky LP, Bringman TS, Palladino MA, Goedel DV (1985) Effect of interleukin 2, interferon-gamma and mitogens on the production of tumor necrosis factor α and β. J Immunol 135:2492-2497
44. North RJ, Havell EA (1988) The antitumor function of tumor necrosis factor, 2. Analysis of the role of endogenous TNFα in endotoxin-induced haemorrhagic necrosis and regression of an established sarcoma. J Exp Med 167:1086-1099
45. Olsson JE, Nilsson K (1979) Gamma-globulins of CSF and serum in MS: isoelectric focusing on polyacrylamide gel and agar gel electrophoresis. Neurology 29: 1383-1391
46. Peter JB, Boctor FN, Tourtelotte WW (1991) Serum and CSF levels of IL-2, SIL-2R, TNFα and IL-β in chrome progressive multiple sclerosis: expected lack of clinical utility. Neurology 41:121-123
47. Poser CM, Paty DW, Scheinberg L, McDonald NI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13:227-231
48. Reinherz EL, Weiner HL, Hauser HL, et al. (1980) Loss of suppressor T cells in active multiple sclerosis. N Engl J Med 303:125-129
49. Robbins DS, Shirazi Y, Drysdale BE, Lieberman A, Shin HS, Shin ML (1988) Production of cytotoxic factor for oligodendrocytes by stimulated astrocytes. J Immunol 139:2593-2597
50. Rostami A, Bruns JB, Brown MJ, Rosen J, Zweiman B, Lisac RP, Pleasure DE (1985) Transfer of experimental allergic neuritis with P2-specific T-cell lines. Cell Immunol 91:354-361
51. Said G, Hontebeyrie-Joskowicz M (1992) Nerve lesions induced by macrophage activation. Res Immunol 143:589-599
52. Schmidt B, Stoll G, Meide P van der, Jung S, Hartung HP (1992) Transient cellular expression of interferon-gamma in myelin-induced and T cell line-mediated experimental autoimmune neuritis. Brain 115:1633-1646
53. Selmaj KW, Raine CS (1988) Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 23:339-246
54. Selmaj KW, Raine CS, Cannella B, Brown CF (1991) Identification of lymphotoxin and TNF in MS lesions. J Clin Invest 87:949-954
55. Sharief MK, Hentges R (1991) Association between TNFα and disease progression in patients with MS. N Engl J Med 325:467-472
56. Shariei MK, McLean B, Thompson EJ (1993) Elevated serum levels of tumor necrosis factorα in GBS. Ann Neurol 33:591-596
57. Tracey KJ, Wei H, Manogue KR, Fong Y, Hesse DG, Ngugen HT, Kuo GC (1988) Cachectin/tumor necrosis factor induces cachexia, anemia and inflammation. J Exp Med 167:1211-1227
58. Traugott O, Scheinberg L, Rainer CS (1979) Multiple sclerosis; circulating antigen reactive lymphocytes. Ann Neurol 6:425-429
59. Tsukada N, Miyagi K, Matsuda M, Yanagisama N, Yone K (1991) TNF and IL-1 in the CSF and sera of patients with MS. J Neurol Sci 102:230-234
60. Waksman BH, Adams RD (1955) Allergic neuritis: an experimental disease of rabbits induced by the injection of peripheral nervous tissue and adjuvants. J Exp Med 102:213-236
61. Weller M, Stevens A, Sommer N, Melcus A, Dichgans J, Wietholter H (1991) Comparative analysis of cytokine patterns in immunological, infectious, and oncological neurological disorders. J Neurol Sci 104:215-221